<svg class="cmark" width="22" height="22" viewBox="0 0 34 34" role="img" aria-label="AP, Healthcare and pharma"><rect width="34" height="34" rx="5" fill="#059669"/><text x="17" y="17" fill="#fff" font-size="14" font-weight="700" text-anchor="middle" dominant-baseline="central" font-family="system-ui,-apple-system,Segoe UI,Roboto,sans-serif">AP</text></svg> Chemicals and pharmaceuticals

AVEO PHARMACEUTICALS, INC.

7 filings mentioning 6 of the compliance and risk topics we track. Every row links to the filing on EDGAR.

7filings we hold
6topics disclosed
Chemicals and pharmaceuticalsindustry
MAbased in

Across 7 filings we hold, AVEO PHARMACEUTICALS, INC. has written down 6 of the topics we track. That places it 540 of 737 companies we hold in chemicals and pharmaceuticals, by how much we have collected.

What it discloses

Tracked topics appearing in this company's filings, most frequent first.

Internal Control4
Material Weakness3
Consent Order1
Restatement1
Ransomware1
Regulatory Reporting1

Bars are scaled against this company's most frequent topic, not against the market. The table below has the exact counts.

TopicFilingsMost recent
Internal Control42022-10-18
Material Weakness32021-03-24
Consent Order12021-02-02
Restatement12021-02-02
Ransomware12021-03-16
Regulatory Reporting12021-05-10

When it filed

Filings we hold, by year. Hover a bar for the count.

19
20
21
22

Recent filings

FiledFormItem
2022-10-188-KEntry into a material agreement, Item 5.03, Other material eventfiling
2021-05-1010-Qfiling
2021-03-248-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2021-03-1610-Kfiling
2021-02-028-KEntry into a material agreement, Item 2.03, Financial statements and exhibitsfiling
2020-06-178-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling
2019-04-048-KEntry into a material agreement, Other material event, Financial statements and exhibitsfiling

Others in chemicals and pharmaceuticals

The companies we hold most on in the same industry. Each opens side by side with this one.

CompanyFilings
OPKOPKO HEALTH, INC.12compare →
FGENFIBROGEN INC12compare →
PTNPALATIN TECHNOLOGIES INC12compare →
OTLCOncotelic Therapeutics, Inc.12compare →
NKTRNEKTAR THERAPEUTICS12compare →
APALEXION PHARMACEUTICALS, INC.12compare →
New here? Signals tracks the compliance and risk language public companies put into their SEC filings, and cross-references it against 723 frameworks and 20,473 controls. See what moved today or check how much of a framework you already cover.

What this page is

Every row comes from SEC full-text search over this company's filings, matched against the compliance and risk phrases we track. It is a record of what the company itself wrote down in documents it is legally accountable for. It is not an assessment of the company, a rating, or a claim about how well it manages anything.

A phrase appearing in a filing frequently means the risk section mentions it, not that an event occurred. Where an item number indicates an actual event, the Item column says so.

All of chemicals and pharmaceuticals · All companies · Today's edition